AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 36115789 — intervention group
Group type: COMPARATOR
Intervention: Routine Technique (RT)
Number of subjects: 60
Study 34483297 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination cognitive behavioral therapy and medication management algorithm (COMB‐R)
Number of subjects: 156
Study 34483297 — intervention group
Group type: COMPARATOR
Intervention: Enhanced standard of care (control)
Number of subjects: 156
Study 35384750 — intervention group
Group type: EXPERIMENTAL
Intervention: Core Training
Number of subjects: 84
Study 35384750 — intervention group
Group type: COMPARATOR
Intervention: Core Training + Consultation
Number of subjects: 84
Study 34348189 — intervention group
Group type: EXPERIMENTAL
Intervention: Empty Chair technique (EC)
Number of subjects: 20
Study 34348189 — intervention group
Group type: COMPARATOR
Intervention: Cognitive Behavioral Therapy technique (CT)
Number of subjects: 20
Study 36259654 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooling intervention
Number of subjects: 12
Study 36259654 — intervention group
Group type: COMPARATOR
Intervention: Control (no cooling)
Number of subjects: 12
Study 36264430 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib cream 0.75%
Number of subjects: 1249
Study 36264430 — intervention group
Group type: EXPERIMENTAL
Intervention: Ruxolitinib cream 1.5%
Number of subjects: 1249
Study 36264430 — intervention group
Group type: COMPARATOR
Intervention: Vehicle cream
Number of subjects: 1249
Study 34193885 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid composition analysis of plasma samples from ALS patients
Number of subjects: 0
Study 34193885 — intervention group
Group type: EXPERIMENTAL
Intervention: Lipid composition analysis of plasma samples from PLS patients
Number of subjects: 0
Study 32935320 — intervention group
Group type: EXPERIMENTAL
Intervention: Parkia platycephala pod meal (PP) and urea (1.5%)
Number of subjects: 4
Study 35172747 — intervention group
Group type: EXPERIMENTAL
Intervention: Propofol-nalbuphine (PN) sedation
Number of subjects: 400
Study 35172747 — intervention group
Group type: COMPARATOR
Intervention: Propofol-fentanyl (PF) sedation
Number of subjects: 400
Study 33585890 — intervention group
Group type: EXPERIMENTAL
Intervention: IVIG + standard of care (SOC)
Number of subjects: 100
Study 33585890 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 100
Study 32133164 — intervention group
Group type: COMPARATOR
Intervention: IYCF + WASH (20g small-quantity lipid-based nutrient supplement/day from 6 to 18 months, complementary feeding counselling, pit latrine, 2 hand-washing stations, liquid soap, chlorine, play space, hygiene counselling)
Number of subjects: 0
Study 32133164 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC (standard-of-care)
Number of subjects: 0
Study 32133164 — intervention group
Group type: COMPARATOR
Intervention: IYCF
Number of subjects: 0
Study 32133164 — intervention group
Group type: COMPARATOR
Intervention: WASH
Number of subjects: 0
Study 35043140 — intervention group
Group type: EXPERIMENTAL
Intervention: Dulaglutide 1.5 mg
Number of subjects: 0
Study 35043140 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34100246 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic redo Heller myotomy (HM)
Number of subjects: 49
Study 34100246 — intervention group
Group type: COMPARATOR
Intervention: Control group (primary laparoscopic HM)
Number of subjects: 49
Study 32340640 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition education programme consisting of twelve 'hands on' nutrition education lessons delivered during the school year
Number of subjects: 523
Study 32340640 — intervention group
Group type: COMPARATOR
Intervention: Control group (preschool classrooms not receiving the intervention)
Number of subjects: 523
Study 33517454 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided fascia iliaca plane block
Number of subjects: 20
Study 32332930 — intervention group
Group type: EXPERIMENTAL
Intervention: Genotype-based warfarin dosing
Number of subjects: 91
Study 32332930 — intervention group
Group type: COMPARATOR
Intervention: Standard warfarin dosing
Number of subjects: 91
Study 35270317 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners in leadership positions (n = 84)
Number of subjects: 366
Study 35270317 — intervention group
Group type: EXPERIMENTAL
Intervention: Employed general practitioners (n = 28)
Number of subjects: 366
Study 35270317 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice assistants (n = 254)
Number of subjects: 366
Study 35270317 — intervention group
Group type: EXPERIMENTAL
Intervention: General practitioners in leadership positions
Number of subjects: 366
Study 35270317 — intervention group
Group type: EXPERIMENTAL
Intervention: Employed physicians
Number of subjects: 366
Study 35270317 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice assistants
Number of subjects: 366
Study 35270317 — intervention group
Group type: COMPARATOR
Intervention: Full-time workers (general practitioners and practice assistants)
Number of subjects: 366
Study 34585897 — intervention group
Group type: COMPARATOR
Intervention: Dapagliflozin
Number of subjects: 0
Study 34284613 — intervention group
Group type: EXPERIMENTAL
Intervention: HTX-011
Number of subjects: 0
Study 34284613 — intervention group
Group type: COMPARATOR
Intervention: bupivacaine HCl
Number of subjects: 0
Study 34284613 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 0
Study 32326325 — intervention group
Group type: EXPERIMENTAL
Intervention: Ticagrelor
Number of subjects: 26
Study 32326325 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 26
Study 32326325 — intervention group
Group type: COMPARATOR
Intervention: No drug (Control)
Number of subjects: 26
Study 32326325 — intervention group
Group type: EXPERIMENTAL
Intervention: Endotoxin administration
Number of subjects: 26
Study 32326325 — intervention group
Group type: EXPERIMENTAL
Intervention: P2Y12 inhibitors (Ticagrelor and Clopidogrel)
Number of subjects: 26
Study 32326325 — intervention group
Group type: EXPERIMENTAL
Intervention: Sepsis patients (n = 41 total; 12 with fatal outcomes, 29 survivors)
Number of subjects: 26
Study 34879006 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitively Based Compassion Training (CBCT)
Number of subjects: 0
Study 34879006 — intervention group
Group type: COMPARATOR
Intervention: Active-attention control
Number of subjects: 0
Study 33070009 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone (7.5 mg twice daily, titrated to maximum 30 mg twice daily)
Number of subjects: 21
Study 33070009 — intervention group
Group type: EXPERIMENTAL
Intervention: Buspirone
Number of subjects: 21
Study 33070009 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 33547969 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-cycle RIC
Number of subjects: 270
Study 33547969 — intervention group
Group type: EXPERIMENTAL
Intervention: Double-cycle RIC
Number of subjects: 270
Study 33547969 — intervention group
Group type: EXPERIMENTAL
Intervention: Both RIC protocols
Number of subjects: 270
Study 33547969 — intervention group
Group type: COMPARATOR
Intervention: Control group without RIC
Number of subjects: 270
Study 35213875 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercises
Number of subjects: 88
Study 35213875 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold exposure training
Number of subjects: 88
Study 35213875 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of cold exposure training and breathing exercise
Number of subjects: 88
Study 35213875 — intervention group
Group type: COMPARATOR
Intervention: No training (Control)
Number of subjects: 88
Study 32701013 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-peptide diagnostic model (m/z 1954.9, m/z 2081.0, m/z 3938.3, m/z 3946.5, and m/z 4268.8)
Number of subjects: 67
Study 32701013 — intervention group
Group type: EXPERIMENTAL
Intervention: Five-peptide diagnostic model
Number of subjects: 67
Study 34678177 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D supplementation (2000 IU/d)
Number of subjects: 11646
Study 34678177 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11646
Study 35320303 — intervention group
Group type: EXPERIMENTAL
Intervention: Hyperventilation
Number of subjects: 24
Study 35320303 — intervention group
Group type: COMPARATOR
Intervention: Diaphragmatic breathing
Number of subjects: 24
Study 35320303 — intervention group
Group type: EXPERIMENTAL
Intervention: First phone call (secondary stressor)
Number of subjects: 24
Study 35921450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinpanemab 250 mg
Number of subjects: 357
Study 35921450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinpanemab 1250 mg
Number of subjects: 357
Study 35921450 — intervention group
Group type: EXPERIMENTAL
Intervention: Cinpanemab 3500 mg
Number of subjects: 357
Study 35921450 — intervention group
Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 357
Study 32636281 — intervention group
Group type: EXPERIMENTAL
Intervention: Optimised background therapy (OBT) plus maraviroc (MVC)
Number of subjects: 60
Study 32636281 — intervention group
Group type: COMPARATOR
Intervention: Optimised background therapy (OBT) alone
Number of subjects: 60
Study 35248285 — intervention group
Group type: COMPARATOR
Intervention: Cervical stabilization exercises
Number of subjects: 28
Study 35248285 — intervention group
Group type: EXPERIMENTAL
Intervention: Scapular stabilization and upper limb proprioceptive exercises + cervical stabilization exercises
Number of subjects: 28
Study 33812750 — intervention group
Group type: EXPERIMENTAL
Intervention: Family economic empowerment (EE) intervention plus bolstered standard of care
Number of subjects: 702
Study 33812750 — intervention group
Group type: COMPARATOR
Intervention: Bolstered standard of care (control)
Number of subjects: 702
Study 33812750 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver social support
Number of subjects: 702
Study 33812750 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-child communication
Number of subjects: 702
Study 33120324 — intervention group
Group type: EXPERIMENTAL
Intervention: Fordyce's fourteen Fundamentals for Happiness Program (8 one-hour group sessions)
Number of subjects: 70
Study 33120324 — intervention group
Group type: COMPARATOR
Intervention: Conventional health-related education (4 one-hour group sessions)
Number of subjects: 70
Study 35872875 — intervention group
Group type: EXPERIMENTAL
Intervention: Whole-body vibration training (WBVT)
Number of subjects: 36
Study 35872875 — intervention group
Group type: COMPARATOR
Intervention: Obese control group
Number of subjects: 36
Study 34029126 — intervention group
Group type: EXPERIMENTAL
Intervention: Er,Cr:YSGG laser (3 W power, 300 mJ energy, 10 Hz frequency, long‐pulsed mode)
Number of subjects: 11
Study 34029126 — intervention group
Group type: COMPARATOR
Intervention: Surgical scalpel
Number of subjects: 11
Study 35889936 — intervention group
Group type: COMPARATOR
Intervention: Isotretinoin
Number of subjects: 50
Study 35889936 — intervention group
Group type: EXPERIMENTAL
Intervention: Isotretinoin + Evening Primrose Oil
Number of subjects: 50
Study 35889936 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (Isotretinoin and Isotretinoin + Evening Primrose Oil)
Number of subjects: 50
Study 33907070 — intervention group
Group type: EXPERIMENTAL
Intervention: Rotary master apical file (RMAF)
Number of subjects: 60
Study 33907070 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasonic activation of endodontic file (UAF)
Number of subjects: 60
Study 33907070 — intervention group
Group type: COMPARATOR
Intervention: Both RMAF and UAF
Number of subjects: 60
Study 32417828 — intervention group
Group type: EXPERIMENTAL
Intervention: Voluntary shift work nurses
Number of subjects: 1259
Study 32417828 — intervention group
Group type: COMPARATOR
Intervention: Forced shift work nurses
Number of subjects: 1259
Study 36241987 — intervention group
Group type: EXPERIMENTAL
Intervention: Online spiritual care training program (4 sessions over 4 weeks)
Number of subjects: 95
Study 36241987 — intervention group
Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 95
Study 33785651 — intervention group
Group type: EXPERIMENTAL
Intervention: ABBV-167 (prodrug of venetoclax)
Number of subjects: 0
Study 33785651 — intervention group
Group type: COMPARATOR
Intervention: Venetoclax tablets
Number of subjects: 0
Study 32614368 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine (L‐SLNB)
Number of subjects: 40
Study 33998885 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidivarin (CBDV) 800 mg twice daily (b.i.d.)
Number of subjects: 162
Study 33998885 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 33998885 — intervention group
Group type: EXPERIMENTAL
Intervention: Cannabidivarin (CBDV)
Number of subjects: 162
Study 32356586 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral methotrexate (MTX) plus narrowband ultraviolet light B (NB‐UVB) phototherapy, 10 mg oral MTX weekly and NB‐UVB sessions twice weekly for 12 weeks
Number of subjects: 90
Study 32356586 — intervention group
Group type: COMPARATOR
Intervention: Oral methotrexate (MTX) monotherapy, 10 mg oral MTX weekly
Number of subjects: 90
Study 34314993 — intervention group
Group type: EXPERIMENTAL
Intervention: Concurrent Treatment of PTSD and Substance Use Disorders using Prolonged Exposure
Number of subjects: 119
Study 34314993 — intervention group
Group type: COMPARATOR
Intervention: Seeking Safety
Number of subjects: 119
Study 32183862 — intervention group
Group type: EXPERIMENTAL
Intervention: Caregiver Support Intervention (CSI)
Number of subjects: 480
Study 32183862 — intervention group
Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 480
Study 36028483 — intervention group
Group type: EXPERIMENTAL
Intervention: gemcitabine and nab-paclitaxel with durvalumab and tremelimumab
Number of subjects: 180
Study 36028483 — intervention group
Group type: COMPARATOR
Intervention: gemcitabine and nab-paclitaxel
Number of subjects: 180
Study 35842004 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5718 200 mg
Number of subjects: 129
Study 35842004 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD5718 50 mg
Number of subjects: 129
Study 35842004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 129
Study 32593521 — intervention group
Group type: EXPERIMENTAL
Intervention: Genetically increased 25(OH)D level
Number of subjects: 7909
Study 35294916 — intervention group
Group type: EXPERIMENTAL
Intervention: EUS-AG
Number of subjects: 58
Study 35294916 — intervention group
Group type: COMPARATOR
Intervention: ERCP-BD
Number of subjects: 58
Study 32183875 — intervention group
Group type: EXPERIMENTAL
Intervention: Autologous adipose-derived stem cells (ADSC)
Number of subjects: 22
Study 32183875 — intervention group
Group type: COMPARATOR
Intervention: Incision-thread-drawing procedure (Control)
Number of subjects: 22
Study 36284992 — intervention group
Group type: EXPERIMENTAL
Intervention: rosuvastatin, amlodipine, Ziyin Huoxue Recipe, and aspirin (experimental group)
Number of subjects: 60
Study 36284992 — intervention group
Group type: COMPARATOR
Intervention: rosuvastatin, amlodipine, Ziyin Huoxue Recipe (observation group)
Number of subjects: 60
Study 33576537 — intervention group
Group type: EXPERIMENTAL
Intervention: Anodal tDCS over the left DLPFC
Number of subjects: 19
Study 33576537 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 19
Study 32553835 — intervention group
Group type: EXPERIMENTAL
Intervention: 90-second animated video intervention
Number of subjects: 1051
Study 34882092 — intervention group
Group type: EXPERIMENTAL
Intervention: Levodopa
Number of subjects: 0
Study 34882092 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 33188208 — intervention group
Group type: EXPERIMENTAL
Intervention: Artificial nectar with added nicotine and anabasine (treatment)
Number of subjects: 16
Study 33188208 — intervention group
Group type: COMPARATOR
Intervention: Artificial nectar without added nicotine and anabasine (control)
Number of subjects: 16
Study 35675174 — intervention group
Group type: EXPERIMENTAL
Intervention: Live group (LG)
Number of subjects: 83
Study 35675174 — intervention group
Group type: COMPARATOR
Intervention: Recorded group (RG)
Number of subjects: 83
Study 34339231 — intervention group
Group type: EXPERIMENTAL
Intervention: Midodrine
Number of subjects: 133
Study 34339231 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 133
Study 32429733 — intervention group
Group type: EXPERIMENTAL
Intervention: Evervac vaccine
Number of subjects: 0
Study 32429733 — intervention group
Group type: COMPARATOR
Intervention: TBE-Moscow vaccine
Number of subjects: 0
Study 34261160 — intervention group
Group type: EXPERIMENTAL
Intervention: Tourniquet used
Number of subjects: 101
Study 34261160 — intervention group
Group type: COMPARATOR
Intervention: No tourniquet used
Number of subjects: 101
Study 33648860 — intervention group
Group type: EXPERIMENTAL
Intervention: Nitrous oxide group
Number of subjects: 88
Study 33648860 — intervention group
Group type: COMPARATOR
Intervention: Air group
Number of subjects: 88
Study 32998931 — intervention group
Group type: EXPERIMENTAL
Intervention: Propranolol and etodolac
Number of subjects: 100
Study 32998931 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 35852684 — intervention group
Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 0
Study 35852684 — intervention group
Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 0
Study 32893151 — intervention group
Group type: EXPERIMENTAL
Intervention: Alloderm
Number of subjects: 62
Study 32893151 — intervention group
Group type: COMPARATOR
Intervention: Dermacell
Number of subjects: 62
Study 35791584 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonazepam
Number of subjects: 60
Study 35791584 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 60
Study 33454782 — intervention group
Group type: EXPERIMENTAL
Intervention: European cooperation packages with greater scope of medicines regulated
Number of subjects: 0
Study 33454782 — intervention group
Group type: EXPERIMENTAL
Intervention: Priority access to most in-need countries
Number of subjects: 0
Study 33454782 — intervention group
Group type: EXPERIMENTAL
Intervention: Delegation to EU-level expertise
Number of subjects: 0
Study 35395216 — intervention group
Group type: EXPERIMENTAL
Intervention: cCBT
Number of subjects: 176
Study 35395216 — intervention group
Group type: EXPERIMENTAL
Intervention: cCBT+Telephone
Number of subjects: 176
Study 35395216 — intervention group
Group type: COMPARATOR
Intervention: Psychoeducation
Number of subjects: 176
Study 34271271 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined acupoints TEAS (PC6 and CV17)
Number of subjects: 576
Study 34271271 — intervention group
Group type: COMPARATOR
Intervention: Sham-operated control
Number of subjects: 576
Study 34271271 — intervention group
Group type: EXPERIMENTAL
Intervention: Single acupoint TEAS (PC6)
Number of subjects: 576
Study 34271271 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined acupoint TEAS (PC6 and CV17)
Number of subjects: 576
Study 35441899 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile device-based resilience training programme
Number of subjects: 21
Study 34904647 — intervention group
Group type: EXPERIMENTAL
Intervention: Negative-pressure wound therapy (NPWT)
Number of subjects: 100
Study 34904647 — intervention group
Group type: COMPARATOR
Intervention: Conventional wound dressing
Number of subjects: 100
Study 33992292 — intervention group
Group type: EXPERIMENTAL
Intervention: Music-based physical therapy
Number of subjects: 13
Study 35063953 — intervention group
Group type: EXPERIMENTAL
Intervention: As-needed low-dose combination budesonide-formoterol
Number of subjects: 74
Study 35063953 — intervention group
Group type: COMPARATOR
Intervention: Maintenance inhaled corticosteroids (ICS)
Number of subjects: 74
Study 33591613 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin
Number of subjects: 227
Study 33591613 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 227
Study 35627855 — intervention group
Group type: EXPERIMENTAL
Intervention: Robotic therapy (30 min)
Number of subjects: 26
Study 35627855 — intervention group
Group type: COMPARATOR
Intervention: Conventional therapy (30 min)
Number of subjects: 26
Study 34521400 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile-app-based instruction coupled with routine cares
Number of subjects: 64
Study 34521400 — intervention group
Group type: COMPARATOR
Intervention: Routine cares
Number of subjects: 64
Study 35093240 — intervention group
Group type: EXPERIMENTAL
Intervention: SY-004 (2 mg)
Number of subjects: 44
Study 35093240 — intervention group
Group type: EXPERIMENTAL
Intervention: SY-004 (20 mg)
Number of subjects: 44
Study 35093240 — intervention group
Group type: EXPERIMENTAL
Intervention: SY-004 (40 mg)
Number of subjects: 44
Study 35093240 — intervention group
Group type: EXPERIMENTAL
Intervention: SY-004 (80 mg)
Number of subjects: 44
Study 35093240 — intervention group
Group type: EXPERIMENTAL
Intervention: SY-004 (120 mg)
Number of subjects: 44
Study 35093240 — intervention group
Group type: COMPARATOR
Intervention: Placebo (20 mg, 40 mg, 80 mg, 120 mg)
Number of subjects: 44
Study 35093240 — intervention group
Group type: EXPERIMENTAL
Intervention: SY-004 (all doses)
Number of subjects: 44
Study 33579857 — intervention group
Group type: EXPERIMENTAL
Intervention: Aerobic exercise training (AET)
Number of subjects: 70
Study 33579857 — intervention group
Group type: COMPARATOR
Intervention: Stretching-and-toning (SAT)
Number of subjects: 70
Study 35640767 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 30
Study 35640767 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 30
Study 34641918 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone wax followed by colostomy paste
Number of subjects: 56
Study 34641918 — intervention group
Group type: COMPARATOR
Intervention: Bone wax alone (control)
Number of subjects: 56
Study 36109026 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone-based cognitive behavioural therapy
Number of subjects: 140
Study 36109026 — intervention group
Group type: COMPARATOR
Intervention: Online COVID‐19 self‐help resources
Number of subjects: 140
Study 33563370 — intervention group
Group type: EXPERIMENTAL
Intervention: Beacon model (GP-based integrated care)
Number of subjects: 5
Study 33563370 — intervention group
Group type: COMPARATOR
Intervention: Usual care (hospital outpatient departments)
Number of subjects: 5
Study 33233981 — intervention group
Group type: EXPERIMENTAL
Intervention: Free eyeglasses
Number of subjects: 832
Study 33233981 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 832
Study 35575067 — intervention group
Group type: EXPERIMENTAL
Intervention: WP1066 at 8 mg/kg
Number of subjects: 8